- Home
- ONCY vs PYXS Comparison
ONCY vs PYXS Comparison
Compare ONCY & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- PYXS
- Stock Information
- Founded
- ONCY 1998
- PYXS 2018
- Country
- ONCY Canada
- PYXS United States
- Employees
- ONCY N/A
- PYXS N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- PYXS Health Care
- Exchange
- ONCY Nasdaq
- PYXS Nasdaq
- Market Cap
- ONCY 86.1M
- PYXS 101.1M
- IPO Year
- ONCY 1999
- PYXS 2021
- Fundamental
- Price
- ONCY $0.79
- PYXS $1.50
- Analyst Decision
- ONCY Strong Buy
- PYXS Strong Buy
- Analyst Count
- ONCY 2
- PYXS 8
- Target Price
- ONCY $4.00
- PYXS $9.43
- AVG Volume (30 Days)
- ONCY 2.4M
- PYXS 817.5K
- Earning Date
- ONCY 03-06-2025
- PYXS 11-12-2024
- Dividend Yield
- ONCY N/A
- PYXS N/A
- EPS Growth
- ONCY N/A
- PYXS N/A
- EPS
- ONCY N/A
- PYXS N/A
- Revenue
- ONCY N/A
- PYXS $16,146,000.00
- Revenue This Year
- ONCY N/A
- PYXS N/A
- Revenue Next Year
- ONCY N/A
- PYXS N/A
- P/E Ratio
- ONCY N/A
- PYXS N/A
- Revenue Growth
- ONCY N/A
- PYXS N/A
- 52 Week Low
- ONCY $0.71
- PYXS $1.39
- 52 Week High
- ONCY $1.53
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- ONCY 38.26
- PYXS 36.16
- Support Level
- ONCY $0.73
- PYXS $1.39
- Resistance Level
- ONCY $0.86
- PYXS $1.82
- Average True Range (ATR)
- ONCY 0.06
- PYXS 0.10
- MACD
- ONCY -0.01
- PYXS 0.03
- Stochastic Oscillator
- ONCY 20.33
- PYXS 25.58
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.